Topics: Patient Engagement
Patient centricity has become an essential element of modern healthcare – in part thanks to the tenacity of patients and caregivers. They have advocated for a place at the table with sponsors and researchers in the drug development process, informing clinical and therapeutic research with much-needed patient voice and perspective.
Too often the word “innovation” conjures a negative response and is synonymous with big change and a total disruption. But innovation is really just the process of translating an idea into a product or service that brings value to a consumer willing to pay for it. It can and should be simple, in both the front and back end.
If you attended our recent webinar “Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement” you had the opportunity to submit a question to BBK President Matt Kibby or Roche Operational Intelligence Leader, Lewis Millen, during the webinar’s Q&A portion. We received so many great and thoughtful questions from our attendees, that we were, unfortunately, unable to address all of them. Today, we are happy to share Matt’s responses to many of those questions here, and we hope you find his answers useful.
During last week’s webinar with BBK President Matt Kibby and Roche’s Operational Intelligence Leader, Lewis Millen, on “Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement,” we had the opportunity to cover a variety of topics and challenges related to mHealth adoption and deployment. And we were pleased to have so many representatives from all areas of clinical R&D, including patients, join us. Lewis was able to provide such valuable insights and if you joined us, you know that first hand.
At BBK Worldwide, we are committed to improving patient engagement through patient-centric technologies and best-practices. Alongside our clinical research partners, we work to boost clinical trial awareness and simplify the clinical trial experience for patients and sites. As the healthcare industry reaffirms its commitment to improving the pathways to improved clinical research, BBK will host Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement, a webinar to discuss what's needed to leverage the power of mHealth and related technologies to the benefit of the study and the study patient on Friday, October 28, 2016 at 12:00 p.m. ET.
About this time each year I blog about how much I hate cancer. This year, it’s a bit tougher as my father was diagnosed with advanced head and neck cancer in June. Once again I am reminded about the difference it makes to be knowledgeable about clinical trials when making treatment decisions. We ask more questions. We explore more options. We filter what we hear through experience. And, we know when the informed consent process isn’t being done well – or even in compliance with regulations.
Over the past 5 years, digital and mobile health technology has evolved to become an indispensable tool for many professionals across the healthcare industry, improving care delivery and expanding access to useful data streams. mHealth apps, wearables and telehealth all come to mind when we think of the industry’s latest innovations, and today, we’ll be discussing another kind of technology that brings an entirely unique dynamic to the healthcare landscape. Hoolux Medical is a company that specializes in medical applications for face detection technology. With a self-contained smart box that sits in a waiting room, Hoolux Medical looks to elevate patients’ health literacy levels by delivering engaging and informative content. We interviewed CEO Ian Gallagher to weigh in on the capabilities of his company's technology and what it means for patients and medical professionals.
This week’s guest post and Focus 5 eBook excerpt comes from Dr. Chris Landon, a pulmonologist with more than 30 years of experience in cystic fibrosis care and the CEO of the Landon Pediatric Foundation. Dr. Landon weighs in on how mHealth continues to impact his own efforts to optimize care and shares his insights on how mobile technologies are re-shaping clinical research and health care.
As organizations across life sciences and health care look to practically apply mHealth solutions in care delivery and clinical research strategies, it is important to better understand these innovations; how and where they’re working best and how they can be further improved. We are pleased to be partnering with Apptomics and we are looking forward to expanding the possibility of these new technologies in their application for neurological disorders and beyond. Dr. Georgia Mitsi, founder and CEO of Apptomics, has created and implemented mHealth solutions in clinical research settings, and in our latest eBook on Next-Gen mHealth, she shares her thoughts on the inner workings of the current mobile health landscape.